Kaunzner UW - Search Results

1

Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.

Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, Mozley PD, Riley CS, Newman SM, Gauthier SA. Kaunzner UW, et al. Mult Scler Relat Disord. 2017 Jul;15:27-33. doi: 10.1016/j.msard.2017.04.008. Epub 2017 Apr 29. Mult Scler Relat Disord. 2017. PMID: 28641769

2

A study of patients with aggressive multiple sclerosis at disease onset.

Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon NN, Vartanian T, Perumal JS. Kaunzner UW, et al. Neuropsychiatr Dis Treat. 2016 Aug 1;12:1907-12. doi: 10.2147/NDT.S111885. eCollection 2016. Neuropsychiatr Dis Treat. 2016. PMID: 27536112 Free PMC article.

3

An Acute Disseminated Encephalomyelitis-Like Illness in the Elderly: Neuroimaging and Neuropathology Findings.

Kaunzner UW, Salamon E, Pentsova E, Rosenblum M, Karimi S, Nealon N, Lavi E, Jamieson DG. Kaunzner UW, et al. J Neuroimaging. 2017 May;27(3):306-311. doi: 10.1111/jon.12409. Epub 2016 Nov 29. J Neuroimaging. 2017. PMID: 27896893 Free PMC article.

4

Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.

Ranganathan U, Kaunzner U, Foster S, Vartanian T, Perumal JS. Ranganathan U, et al. Mult Scler. 2018 Apr;24(4):540-542. doi: 10.1177/1352458517699876. Epub 2017 Mar 13. Mult Scler. 2018. PMID: 28287030

5

Defining Disease Activity and Response to Therapy in MS.

Kaunzner UW, Al-Kawaz M, Gauthier SA. Kaunzner UW, et al. Curr Treat Options Neurol. 2017 May;19(5):20. doi: 10.1007/s11940-017-0454-5. Curr Treat Options Neurol. 2017. PMID: 28451934 Review.

6

MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.

Kaunzner UW, Gauthier SA. Kaunzner UW, et al. Ther Adv Neurol Disord. 2017 Jun;10(6):247-261. doi: 10.1177/1756285617708911. Epub 2017 May 12. Ther Adv Neurol Disord. 2017. PMID: 28607577 Free PMC article. Review.

7

Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis.

Ranganathan U, Kaunzner U, Foster S, Vartanian T, Perumal JS. Ranganathan U, et al. Mult Scler. 2018 Apr;24(4):553-554. doi: 10.1177/1352458517719152. Epub 2017 Jun 29. Mult Scler. 2018. PMID: 28661221 No abstract available.

8

Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.

Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS. Kocsik AS, et al. Among authors: kaunzner uw. J Neurol. 2018 May;265(5):1226-1229. doi: 10.1007/s00415-018-8845-4. Epub 2018 Apr 17. J Neurol. 2018. PMID: 29666985

9

Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.

Kang Y, Schlyer D, Kaunzner UW, Kuceyeski A, Kothari PJ, Gauthier SA. Kang Y, et al. Among authors: kaunzner uw. PLoS One. 2018 Aug 9;13(8):e0201289. doi: 10.1371/journal.pone.0201289. eCollection 2018. PLoS One. 2018. PMID: 30091993 Free PMC article.

10

Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions.

Kaunzner UW, Kang Y, Zhang S, Morris E, Yao Y, Pandya S, Hurtado Rua SM, Park C, Gillen KM, Nguyen TD, Wang Y, Pitt D, Gauthier SA. Kaunzner UW, et al. Brain. 2019 Jan 1;142(1):133-145. doi: 10.1093/brain/awy296. Brain. 2019. PMID: 30561514 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters